Breast tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Model 1: Early diagnosis of breast cancer and differentiation of benign and malignant breast masses: Inclusion criteria were as follows: 1. Patients admitted for puncture or surgical excision of breast masses found in our outpatient clinic or outside hospital, with routine preoperative breast ultrasound examination 2. Good quality of ultrasound images 3. confirmed by puncture or surgical pathological biopsy 4. age > 18 years, and 18 years, and 18 years, and< 80 years
Exclusion criteria
Exclusion criteria: Model 1: Early diagnosis of breast cancer and differentiation of benign and malignant breast masses Nullification criteria: The exclusion criteria are as follows: 1. Poor image quality, unable to extract features 3. No puncture biopsy or surgical histology results were obtained Model 2: Prediction of the efficacy of neoadjuvant chemotherapy NAC for breast cancer Exclusion criteria are as follows 1. Patients who did not complete the NAC regimen or received non-standard treatment (mainly HER-2 positive patients who did not receive trastuzumab) 2. Poor image quality and inability to extract features 3, lack of ultrasound images of a particular phase or incomplete multimodality ultrasound images of a particular phase 4Patients with multicentric or multifocal cancer with uncertain correlation between the lesion on the ultrasound image and postoperative pathological analysis 5. distant metastases Model III: Prognostic assessment after breast cancer surgery Exclusion criteria: 1. NAC patients who have not completed the NAC protocol or who are receiving non-standard treatment (mainly HER-2 positive patients who are not receiving trastuzumab) 2. Poor image quality and inability to extract features 3. Lack of ultrasound images of a particular stage or incomplete multimodality ultrasound images of a particular stage 4. Preoperative distant metastases 5. Incomplete clinically relevant information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multi-temporal multimodal ultrasound images;Pre-operative puncture pathology images;Integration of ultrasound and pathology image multimodality;Type of puncture or surgical pathology mass;Complete remission of neoadjuvant chemotherapy pathology;Disease-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Size of primary focus;Age at first diagnosis;Menopausal state;Hormone receptor;Human epidermal growth factor receptor-2;Ki-67;Molecular subtype;Histologic typing;Types of breast cancer;Neoadjuvant chemotherapy treatment protocols;Tumor staging; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Traditional Chinese Medicine